PROCEPT BioRobotics Corporation logo

PROCEPT BioRobotics Corporation (PRCT) Q3 2024 Earnings

PRCT·Reported October 28, 2024·Before market open

PROCEPT BioRobotics Corporation reported Q3 2024 revenue of $58.4M, missed analyst consensus of $66.8M by $8.4M. Diluted EPS came in at $-0.40, beat the $-0.48 consensus by $0.08.

Revenue
$58.4Mmissed by $8.4M
Consensus: $66.8M
Diluted EPS
$-0.40beat by $0.08
Consensus: $-0.48
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q3 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q3 2024 Earnings FAQ

Common questions about PROCEPT BioRobotics Corporation's Q3 2024 earnings report.

PROCEPT BioRobotics Corporation (PRCT) reported Q3 2024 earnings on October 28, 2024 before market open.

PROCEPT BioRobotics Corporation reported revenue of $58.4M and diluted EPS of $-0.40 for Q3 2024.

Revenue missed the consensus estimate of $66.8M by $8.4M. EPS beat the consensus estimate of $-0.48 by $0.08.

You can read the 10-Q periodic report (0001588978-24-000030) directly on SEC EDGAR. The filing index links above go to sec.gov.